Your session is about to expire
← Back to Search
Behavioral Intervention
Participants for Drug Overdose
N/A
Waitlist Available
Led By Katherine Rittenbach, PhD
Research Sponsored by AHS Cancer Control Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
To help prevent deaths in populations that cannot or will not access physical safer consumption services in Alberta, which may disproportionately include women and those who are not able to self-inject (Potier et al., 2014) the investigators propose to provide virtual (phone-based) supervised consumption services, staffed by people with lived experience.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Usage
Secondary outcome measures
EMS dispatch outcome
EMS response time
Other outcome measures
Health care usage
Length of calls
Proportion of calls for which EMS is dispatched
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: ParticipantsExperimental Treatment1 Intervention
All participants will be given the phone number and encouraged to call any time they plan to use substances alone
Find a Location
Who is running the clinical trial?
AHS Addiction and Mental Health Strategic Clinical NetworkUNKNOWN
TELUSUNKNOWN
2 Previous Clinical Trials
366 Total Patients Enrolled
AHS Cancer Control AlbertaLead Sponsor
182 Previous Clinical Trials
36,212 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger